US FDA Approval Of Novo Nordisk's Victoza For Young T2D Patients A Treatment Milestone

 
• By Sten Stovall

The new indication means Victoza is the first non-insulin drug approved to treat type 2 diabetes in young patients since metformin was approved for pediatric use in 2000. Victoza has been approved to treat adult patients with type 2 diabetes since 2010.

Blood sample
Move Gives Young T2D patients First New Treatment Option In Nearly 20 Years • Source: Shutterstock

More from New Products

More from Scrip